Leah Cann

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Leah Cann works at BROOKLINE and is focused on the Healthcare sector with 130 price targets and ratings documented since 2016 spanning on 14 stocks. Previously, Leah Cann worked at OPPENHEIMER. Analyst's average stock valuation to be materialised ratio is 41.67% with an average time for price targets to be met of 191.5 days.

Most recent stock forecast was given on MRNA, Moderna, Inc at 22-Jun-2022.

Leah Cann best performing recommendations are on SYRS.
The best stock recommendation documented was for MRNA (MODERNA, INC) at 11/25/2020. The price target of $164 was fulfilled within 13 days with a profit of $54.82 (50.21%) receiving and performance score of 38.62.

Average potential price target upside

Currently, out of the existing stock ratings of Leah Cann - 2708 which are a Buy (98.76%), 34 which are a Hold (1.24%)

AMGN CELG CTIC MEIP MRNA SQZ CCCC CRBU KURA SYRS MRTX NTLA VSTM XFOR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

265

$26.52 (11.12%)

275

16 days ago

3/7 (42.86%)

$29.16 (12.54%)

377

Hold

260

$21.52 (9.02%)

280

1 months 16 days ago

26/27 (96.3%)

$42.93 (26.07%)

638

Sell

230

$-8.48 (-3.56%)

240

1 months 27 days ago

16/16 (100%)

$10.47 (7.10%)

219

Hold

253

$14.52 (6.09%)

276

1 months 27 days ago

16/18 (88.89%)

$34.97 (17.12%)

390

Buy

294

$55.52 (23.28%)

312

1 months 27 days ago

18/22 (81.82%)

$41.89 (18.96%)

533

Show more analysts
AMGN CELG CTIC MEIP MRNA SQZ CCCC CRBU KURA SYRS MRTX NTLA VSTM XFOR